Skip to content
10-K

Annual Report

INTERNATIONAL STEM CELL CORPORATION ISCO

0000950170-25-046745

← back to feed
Filed
Mar 28, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 25, 2025 8M sh
Shares Diluted FY 2024 · Dec 31, 2023 8M sh
Capex FY 2024 · Dec 31, 2023 $80K
Operating Cash Flow FY 2024 · Dec 31, 2023 $929K
Current Liabilities FY 2024 · Dec 31, 2023 $4.83M
Total Liabilities FY 2024 · Dec 31, 2023 $5.28M
Current Assets FY 2024 · Dec 31, 2023 $3.52M
Total Assets FY 2024 · Dec 31, 2023 $5.39M
Eps Diluted FY 2024 · Dec 31, 2023 −$0.02
Eps Basic FY 2024 · Dec 31, 2023 −$0.02
Sga Expense FY 2024 · Dec 31, 2023 $3.51M
Rd Expense FY 2024 · Dec 31, 2023 $511K
Net Income FY 2024 · Dec 31, 2023 −$131K
Operating Income FY 2024 · Dec 31, 2023 −$663K
Cost Of Revenue FY 2024 · Dec 31, 2023 $3.18M
Revenue FY 2024 · Dec 31, 2023 $7.79M
Stockholders Equity FY 2024 · Dec 31, 2022 −$4.52M